James Tobin Insider Profile
11 Followers
James Tobin, Director at Globus Medical, holds 0.00 shares in Globus Medical (Ticker: GMED), holds 158.07K shares in TransMedics Group (Ticker: TMDX), holds 0.00 shares in Oxford Immunotec (Ticker: OXFD).
James Tobin's Trading History
| TMDXTransMedics Group | Nov 12, 2026 | Director | Informative Sell | 385.46K | $14.44M | |
| GMEDGlobus Medical | Nov 12, 2026 | Director | Uninformative Buy | 2.35M | $0.00 | |
| OXFDOxford Immunotec | Mar 12, 2021 | ― | Uninformative Sell | 89.78K | $0.00 | |
| CVRSCorindus Vascular Robotics | Oct 31, 2019 | ― | Uninformative Sell | 454.16K | $0.00 | |
| CRISCuris | May 07, 2013 | Director | Uninformative Sell | 151.84K | $64.49K | |
| BSXBoston Scientific | ― | President & CEO, Director | ― | $25.12M | ||
| LYRALyra Therapeutics | ― | Director | ― | ― | ||
| CHMAChiasma | ― | ― | ― | $0.00 |
You May Also Like
James Tobin insider profile FAQ
What is the percentage of profitable transactions made by James Tobin?
The percentage of profitable transactions made by James Tobin is 73%.
What is the average return per transaction made by James Tobin?
The average return per transaction made by James Tobin is -0.60%.
What stocks does James Tobin hold?
James Tobin holds: GMED, CRIS, CVRS, CHMA, OXFD, TMDX, LYRA, BSX stocks.
What was James Tobin’s latest transaction?
James Tobin’s latest transaction was an Uninformative Buy of $2.35M.
What was James Tobin's most profitable transaction?
James Tobin’s most profitable transaction was an Informative Sell of TMDX stock on August 9, 2024. The return on the trade was 29.70%.
What is James Tobin's role in Globus Medical?
James Tobin's role in Globus Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
